These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17932160)

  • 1. Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials.
    Lam SK; Owen A
    BMJ; 2007 Nov; 335(7626):925. PubMed ID: 17932160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is combined resynchronisation and implantable defibrillator therapy a cost-effective option for left ventricular dysfunction?
    Bond M; Mealing S; Anderson R; Dean J; Stein K; Taylor RS
    Int J Cardiol; 2009 Nov; 137(3):206-15. PubMed ID: 18703244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of implantable cardioverter defibrillator and cardiac resynchronisation therapy in heart failure management.
    Chia PL; Foo D
    Singapore Med J; 2016 Jul; 57(7):354-9. PubMed ID: 27440409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.
    Colquitt JL; Mendes D; Clegg AJ; Harris P; Cooper K; Picot J; Bryant J
    Health Technol Assess; 2014 Aug; 18(56):1-560. PubMed ID: 25169727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable cardiac defibrillators for people with non-ischaemic cardiomyopathy.
    El Moheb M; Nicolas J; Khamis AM; Iskandarani G; Akl EA; Refaat M
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012738. PubMed ID: 30537022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of a risk-stratified approach to cardiac resynchronisation therapy defibrillators (high versus low) at the time of generator change.
    Claridge S; Sebag FA; Fearn S; Behar JM; Porter B; Jackson T; Sieniewicz B; Gould J; Webb J; Chen Z; O'Neill M; Gill J; Leclercq C; Rinaldi CA
    Heart; 2018 Mar; 104(5):416-422. PubMed ID: 28970277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of cardiac resynchronisation therapy devices and implantable cardioverter defibrillators in the treatment of heart failure due to severe systolic dysfunction: systematic review of clinical trials and network meta-analysis.
    García García MA; Rosero Arenas MA; Ruiz Granell R; Chorro Gascó FJ; Martínez Cornejo A
    Heart Asia; 2016; 8(1):8-15. PubMed ID: 27326223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: a meta-analysis of > 35,000 patients.
    Peck KY; Lim YZ; Hopper I; Krum H
    Int J Cardiol; 2014 May; 173(2):197-203. PubMed ID: 24636548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter-defibrillators and survival in advanced heart failure patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysis.
    Elkaryoni A; Badarin FA; Khan MS; Ellakany K; Potturi N; Poonia J; Kennedy KF; Magalski A; Sperry BW; Wimmer AP
    Europace; 2019 Sep; 21(9):1353-1359. PubMed ID: 31086951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices.
    Lin G; Rea RF; Hammill SC; Hayes DL; Brady PA
    Heart; 2008 Feb; 94(2):186-90. PubMed ID: 17761506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do implantable cardioverter defibrillators improve survival in patients with severe left ventricular systolic dysfunction after coronary artery bypass graft surgery?
    Fazal IA; Bates MG; Matthews IG; Turley AJ
    Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):1010-6. PubMed ID: 21398652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials?
    Coats AJ
    Int J Cardiol; 2002 Jan; 82(1):1-5. PubMed ID: 11786150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Implantable defibrillator and ventricular resynchronisation].
    Jego C; Deharo JC
    Arch Mal Coeur Vaiss; 2004 Nov; 97(11):1122-9. PubMed ID: 15609915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac resynchronization therapy and implantable cardiac defibrillators in left ventricular systolic dysfunction.
    McAlister FA; Ezekowitz J; Dryden DM; Hooton N; Vandermeer B; Friesen C; Spooner C; Rowe BH
    Evid Rep Technol Assess (Full Rep); 2007 Jun; (152):1-199. PubMed ID: 17764218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).
    Zareba W; Piotrowicz K; McNitt S; Moss AJ;
    Am J Cardiol; 2005 Jun; 95(12):1487-91. PubMed ID: 15950580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE).
    Gold MR; Daubert JC; Abraham WT; Hassager C; Dinerman JL; Hudnall JH; Cerkvenik J; Linde C
    Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1163-8. PubMed ID: 24125796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardiac defibrillator and mortality in non-ischaemic cardiomyopathy: an updated meta-analysis.
    Alba AC; Foroutan F; Duero Posada J; Battioni L; Schofield T; Alhussein M; Agoritsas T; Spencer FA; Guyatt G
    Heart; 2018 Feb; 104(3):230-236. PubMed ID: 28780582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.